Modulation of silent and constitutively active nociceptin/orphanin FQ receptors by potent receptor antagonists and Na+ Ions in rat sympathetic neurons

Molecular Pharmacology

Volumn 77, Issue 5, 2010, Pages 804-817

  Mahmoud, Saifeldin ^a   Margas, Wojciech ^a   Trapella, Claudio ^b   Caló, Girolamo ^b   Ruiz Velasco, Victor ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL N [3 [SPIROISOBENZOFURAN 1(3H),4' PIPERIDIN 1 YL]PROPYL]PYRROLIDINE 2 CARBOXAMIDE; CALCIUM CHANNEL; G PROTEIN COUPLED RECEPTOR; MU OPIATE RECEPTOR; N (4 AMINO 2 METHYL 6 QUINOLINYL) 2 (4 ETHYLPHENOXYMETHYL)BENZAMIDE; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR ANTAGONIST; PARTIAL AGONIST; PERTUSSIS TOXIN; SODIUM ION; TRAP 101; UFP 101; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; DRUG EFFECT; FACILITATION; GENETIC TRANSFECTION; HETEROLOGOUS EXPRESSION; IC 50; INVERSE AGONISM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SYMPATHETIC NERVE CELL;

ANIMALS; CALCIUM; DNA, COMPLEMENTARY; ELECTROPHYSIOLOGY; NEURONS; OPIOID PEPTIDES; PLASMIDS; RATS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU; SODIUM; SYMPATHETIC NERVOUS SYSTEM; TRANSFECTION;

EID: 77951085948     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.062208     Document Type: Article

References (38)

1. Andoh T, Itoh M, and Kuraishi Y (1997) Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation. Neuroreport 8:2793-2796. (Pubitemid 27373531)
2. Ardati A, Henningsen RA, Higelin J, Reinscheid RK, Civelli O, and Monsma FJ Jr (1997) Interaction of [3H]orphanin FQ and 125I-Tyr14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides. Mol Pharmacol 51:816-824. (Pubitemid 27224687)
3. Barnes TA, McDonald J, Rowbotham DJ, Duarte TL, and Lambert DG (2007) Effects of receptor density on Nociceptin/OrphaninFQ peptide receptor desensitisation: studies using the ecdysone inducible expression system. Naunyn Schmiedebergs Arch Pharmacol 376:217-225. (Pubitemid 350029410)
4. Beedle AM, McRory JE, Poirot O, Doering CJ, Altier C, Barrere C, Hamid J, Nargeot J, Bourinet E, and Zamponi GW (2004) Agonist-independent modulation of N-type calcium channels by ORL1 receptors. Nat Neurosci 7:118-125. (Pubitemid 38129787)
5. Briscini L, Corradini L, Ongini E, and Bertorelli R (2002) Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury. Eur J Pharmacol 447:59-65. (Pubitemid 34775221)
6. Butour JL, Moisand C, Mazarguil H, Mollereau C, and Meunier JC (1997) Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids. Eur J Pharmacol 321:97-103. (Pubitemid 27096621)
7. Calo G, Guerrini R, Rizzi A, Salvadori S, Burmeister M, Kapusta DR, Lambert DG, and Regoli D (2005) UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor. CNS Drug Rev 11:97-112. (Pubitemid 41278976)
8. Costa T and Herz A (1989) Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA 86:7321-7325. (Pubitemid 19254452)
9. Costa T, Lang J, Gless C, and Herz A (1990) Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions. Mol Pharmacol 37:383-394. (Pubitemid 20115596)
10. De Castro F, Geijo-Barrientos E, and Gallego R (1997) Calcium-activated chloride current in normal mouse sympathetic ganglion cells. J Physiol 498:397-408. (Pubitemid 27073384)
11. de Ligt RA, Kourounakis AP, and IJzerman AP (2000) Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery. Br J Pharmacol 130:1-12.
12. Dooley CT and Houghten RA (2000) Orphanin FQ/nociceptin receptor binding studies. Peptides 21:949-960.
13. Fischetti C, Camarda V, Rizzi A, Pelà M, Trapella C, Guerrini R, McDonald J, Lambert DG, Salvadori S, Regoli D, et al. (2009) Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. Eur J Pharmacol 614:50-57.
14. Fuller BC, Sumner AD, Kutzler MA, and Ruiz-Velasco V (2004) A novel approach employing ultrasound guidance for percutaneous cardiac muscle injection to retrograde label rat stellate ganglion neurons. Neurosci Lett 363:252-256.
15. Goto Y, Arai-Otsuki S, Tachibana Y, Ichikawa D, Ozaki S, Takahashi H, Iwasawa Y, Okamoto O, Okuda S, Ohta H, et al. (2006) Identification of a novel spiropiperidine opioid receptor-like 1 antagonist class by a focused library approach featuring 3D-pharmacophore similarity. J Med Chem 49:847-849. (Pubitemid 43221632)
16. Ikeda SR (1991) Double-pulse calcium channel current facilitation in adult rat sympathetic neurones. J Physiol 439:181-214.
17. Ikeda SR (2004) Expression of G-protein signaling components in adult mammalian neurons by microinjection. Methods Mol Biol 259:167-181.
18. Jia Y, Linden DR, Serie JR, and Seybold VS (1998) Nociceptin/orphanin FQ binding increases in superficial laminae of the rat spinal cord during persistent peripheral inflammation. Neurosci Lett 250:21-24. (Pubitemid 28341767)
19. Ko MH, Kim YH, Woo RS, and Kim KW (2002) Quantitative analysis of nociceptin in blood of patients with acute and chronic pain. Neuroreport 13:1631-1633.
20. Lambert DG (2008) The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat Rev Drug Discov 7:694-710.
21. Margas W, Sedeek K, and Ruiz-Velasco V (2008) Coupling specificity of NOP opioid receptors to pertussis-toxin-sensitive Galpha proteins in adult rat stellate ganglion neurons using small interference RNA. J Neurophysiol 100:1420-1432.
22. Marti M, Stocchi S, Paganini F, Mela F, De Risi C, Calo' G, Guerrini R, Barnes TA, Lambert DG, Beani L, et al. (2003) Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex. Br J Pharmacol 138:91-98. (Pubitemid 36194207)
23. McDonald J, Barnes TA, Okawa H, Williams J, Calo' G, Rowbotham DJ, and Lambert DG (2003) Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression: studies using the ecdysone-inducible mammalian expression system. Br J Pharmacol 140:61-70. (Pubitemid 37175831)
24. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, and Monsarrat B (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377:532-535.
25. Mika J, Schäfer MK, Obara I, Weihe E, and Przewlocka B (2004) Morphine and endomorphin-1 differently influence pronociceptin/orphanin FQ system in neuropathic rats. Pharmacol Biochem Behav 78:171-178. (Pubitemid 38670526)
26. Milligan G and Smith NJ (2007) Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends Pharmacol Sci 28:615-620. (Pubitemid 350166577)
27. Mogil JS and Pasternak GW (2001) The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 53:381-415.
28. Olianas MC and Onali P (2003) Sodium ions and GTP decrease the potency of [Nphe1]N/OFQ(1-13)NH2 in blocking nociceptin/orphanin FQ receptors coupled to cyclic AMP in N1E-115 neuroblastoma cells and rat olfactory bulb. Life Sci 72:2905-2914.
29. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr, and Civelli O (1995) Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270:792-794.
30. 2+ channels by opioid receptor-like 1 receptors natively expressed in rat stellate ganglion neurons innervating cardiac muscle. J Pharmacol Exp Ther 314:987-994.
31. Seifert R and Wenzel-Seifert K (2002) Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 366:381-416. (Pubitemid 35251788)
32. Shinkai H, Ito T, Iida T, Kitao Y, Yamada H, and Uchida I (2000) 4-Aminoquinolines: novel nociceptin antagonists with analgesic activity. J Med Chem 43:4667-4677.
33. Strange PG (2002) Mechanisms of inverse agonism at G-protein-coupled receptors. Trends Pharmacol Sci 23:89-95. (Pubitemid 34119331)
34. Trapella C, Fischetti C, Pela' M, Lazzari I, Guerrini R, Calo' G, Rizzi A, Camarda V, Lambert DG, McDonald J, et al. (2009) Structure-activity studies on the nociceptin/ orphanin FQ receptor antagonist 1-benzyl-N-{3- [spiroisobenzofuran-1(3H),4′- piperidin-1-yl]propyl} pyrrolidine-2- carboxamide. Bioorg Med Chem 17:5080-5095.
35. Trapella C, Guerrini R, Piccagli L, Calo' G, Carra' G, Spagnolo B, Rubini S, Fanton G, Hebbes C, McDonald J, et al. (2006) Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist. Bioorg Med Chem 14:692-704. (Pubitemid 41767573)
36. Zaveri N, Jiang F, Olsen C, Polgar W, and Toll L (2005) Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): ligand-based analysis of structural factors influencing intrinsic activity at NOP. AAPS J 7:E345-E352. (Pubitemid 43078601)
37. Zeilhofer HU and Calò G (2003) Nociceptin/orphanin FQ and its receptor-potential targets for pain therapy? J Pharmacol Exp Ther 306:423-429.
38. Zhu Y and Ikeda SR (1993) Anomalous permeation of Na+ through a putative K+ channel in rat superior cervical ganglion neurones. J Physiol 468:441-461. (Pubitemid 23254455)